• Home
  • Pharmaceuticals and Healthcare
Global Peripheral Parenteral Nutrition (PPN) Market Opportunities and Forecast 2022-2028

Global Peripheral Parenteral Nutrition (PPN) Market Opportunities and Forecast 2022-2028

Report Code: KNJ1329803 | No. of Pages: | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: May-2022 
This report provides a comprehensive analysis of current global Peripheral Parenteral Nutrition (PPN) market based on segmented types and downstream applications. Major product development trends are discussed  under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Peripheral Parenteral Nutrition (PPN) industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to GRD Survey, the global Peripheral Parenteral Nutrition (PPN) market is estimated at $  million in 2021, and projected to grow at a CAGR of % to $  million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Peripheral Parenteral Nutrition (PPN) Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Peripheral Parenteral Nutrition (PPN) market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Peripheral Parenteral Nutrition (PPN) Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Peripheral Parenteral Nutrition (PPN) industry. 
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis. 
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
    Carbohydrates
    Parenteral Lipid Emulsion
    Single Dose Amino Acid Solution
    Trace Elements
    Vitamins and Minerals

Segmented by Application
    Hospital
    Home

Segmented by Country
    North America
        United States
        Canada
        Mexico
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
    Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
    Central & South America
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

Key manufacturers included in this survey
    Teva Pharmaceutical Industries

    Sichuan Kelun Pharmaceutical

    Pfizer (Hospira)

    Ostuka Pharmaceutical

    Laboratorios Finlay

    Laboratorios Biogalenic

    Kelun Pharma

    Grifols International

    Fresenius

    Fresenius Kabi

    Eurofarma

    Corporacion De Laboratorios Farmaceuticos

    Baxter International Inc.

    B. Braun



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Peripheral Parenteral Nutrition (PPN) Market Status and Forecast (2017-2028)
        1.3.2 Global Peripheral Parenteral Nutrition (PPN) Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Peripheral Parenteral Nutrition (PPN) Supply by Company
    2.1 Global Peripheral Parenteral Nutrition (PPN) Sales Value by Company
    2.2 Peripheral Parenteral Nutrition (PPN) Sales Area of Main Manufacturers
    2.3 Trend of Concentration Rate
3 Global and Regional Peripheral Parenteral Nutrition (PPN) Market Status by Type
    3.1 Peripheral Parenteral Nutrition (PPN) Type Introduction
        3.1.1 Carbohydrates
        3.1.2 Parenteral Lipid Emulsion
        3.1.3 Single Dose Amino Acid Solution
        3.1.4 Trace Elements
        3.1.5 Vitamins and Minerals
    3.2 Global Peripheral Parenteral Nutrition (PPN) Market by Type
    3.3 North America: by Type
    3.4 Europe: by Type
    3.5 Asia Pacific: by Type
    3.6 Central & South America: by Type
    3.7 Middle East & Africa: by Type
4 Global and Regional Peripheral Parenteral Nutrition (PPN) Market Status by Application
    4.1 Peripheral Parenteral Nutrition (PPN) Segment by Application
        4.1.1 Hospital
        4.1.2 Home
    4.2 Global Peripheral Parenteral Nutrition (PPN) Market by Application
    4.3 North America: by Application
    4.4 Europe: by Application
    4.5 Asia Pacific: by Application
    4.6 Central & South America: by Application
    4.7 Middle East & Africa: by Application
5 Global Peripheral Parenteral Nutrition (PPN) Market Status by Region
    5.1 Global Peripheral Parenteral Nutrition (PPN) Market by Region
    5.2 North America Peripheral Parenteral Nutrition (PPN) Market Status
    5.3 Europe Peripheral Parenteral Nutrition (PPN) Market Status
    5.4 Asia Pacific Peripheral Parenteral Nutrition (PPN) Market Status
    5.5 Central & South America Peripheral Parenteral Nutrition (PPN) Market Status
    5.6 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Status
6 North America Peripheral Parenteral Nutrition (PPN) Market Status
    6.1 North America Peripheral Parenteral Nutrition (PPN) Market by Country
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Peripheral Parenteral Nutrition (PPN) Market Status
    7.1 Europe Peripheral Parenteral Nutrition (PPN) Market by Country
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Peripheral Parenteral Nutrition (PPN) Market Status
   8.1 Asia Pacific Peripheral Parenteral Nutrition (PPN) Market by Country
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Peripheral Parenteral Nutrition (PPN) Market Status
    9.1 Central & South America Peripheral Parenteral Nutrition (PPN) Market by Country
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Status
    10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market by Country
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Major Downstream Customers Analysis
    11.1 Customer One Analysis
    11.2 Customer Two Analysis
    11.3 Customer Three Analysis
    11.4 Customer Four Analysis
12 Global Peripheral Parenteral Nutrition (PPN) Market Forecast by Type and by Application
    12.1 Global Peripheral Parenteral Nutrition (PPN) Sales Value Forecast (2023-2028)
    12.2 Global Peripheral Parenteral Nutrition (PPN) Forecast by Type
    12.3 Global Peripheral Parenteral Nutrition (PPN) Forecast by Application
13 Global Peripheral Parenteral Nutrition (PPN) Market Forecast by Region/Country
    13.1 Global Peripheral Parenteral Nutrition (PPN) Market Forecast by Region (2023-2028)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 Teva Pharmaceutical Industries

        14.1.1 Company Information
        14.1.2 Peripheral Parenteral Nutrition (PPN) Product Introduction
        14.1.3 Teva Pharmaceutical Industries
 Peripheral Parenteral Nutrition (PPN) Sales Value, Gross Margin and Global Share (2020-2022)
        14.1.4 SWOT Analysis
    14.2 Sichuan Kelun Pharmaceutical

        14.2.1 Company Information
        14.2.2 Peripheral Parenteral Nutrition (PPN) Product Introduction
        14.2.3 Sichuan Kelun Pharmaceutical
 Peripheral Parenteral Nutrition (PPN) Sales Value, Gross Margin and Global Share (2020-2022)
        14.2.4 SWOT Analysis
    14.3 Pfizer (Hospira)

        14.3.1 Company Information
        14.3.2 Peripheral Parenteral Nutrition (PPN) Product Introduction
        14.3.3 Pfizer (Hospira)
 Peripheral Parenteral Nutrition (PPN) Sales Value, Gross Margin and Global Share (2020-2022)
        14.3.4 SWOT Analysis
    14.4 Ostuka Pharmaceutical

        14.4.1 Company Information
        14.4.2 Peripheral Parenteral Nutrition (PPN) Product Introduction
        14.4.3 Ostuka Pharmaceutical
 Peripheral Parenteral Nutrition (PPN) Sales Value, Gross Margin and Global Share (2020-2022)
        14.4.4 SWOT Analysis
    14.5 Laboratorios Finlay

        14.5.1 Company Information
        14.5.2 Peripheral Parenteral Nutrition (PPN) Product Introduction
        14.5.3 Laboratorios Finlay
 Peripheral Parenteral Nutrition (PPN) Sales Value, Gross Margin and Global Share (2020-2022)
        14.5.4 SWOT Analysis
    14.6 Laboratorios Biogalenic

        14.6.1 Company Information
        14.6.2 Peripheral Parenteral Nutrition (PPN) Product Introduction
        14.6.3 Laboratorios Biogalenic
 Peripheral Parenteral Nutrition (PPN) Sales Value, Gross Margin and Global Share (2020-2022)
        14.6.4 SWOT Analysis
    14.7 Kelun Pharma

        14.7.1 Company Information
        14.7.2 Peripheral Parenteral Nutrition (PPN) Product Introduction
        14.7.3 Kelun Pharma
 Peripheral Parenteral Nutrition (PPN) Sales Value, Gross Margin and Global Share (2020-2022)
        14.7.4 SWOT Analysis
    14.8 Grifols International

        14.8.1 Company Information
        14.8.2 Peripheral Parenteral Nutrition (PPN) Product Introduction
        14.8.3 Grifols International
 Peripheral Parenteral Nutrition (PPN) Sales Value, Gross Margin and Global Share (2020-2022)
        14.8.4 SWOT Analysis
    14.9 Fresenius

        14.9.1 Company Information
        14.9.2 Peripheral Parenteral Nutrition (PPN) Product Introduction
        14.9.3 Fresenius
 Peripheral Parenteral Nutrition (PPN) Sales Value, Gross Margin and Global Share (2020-2022)
        14.9.4 SWOT Analysis
    14.10 Fresenius Kabi

        14.10.1 Company Information
        14.10.2 Peripheral Parenteral Nutrition (PPN) Product Introduction
        14.10.3 Fresenius Kabi
 Peripheral Parenteral Nutrition (PPN) Sales Value, Gross Margin and Global Share (2020-2022)
        14.10.4 SWOT Analysis
    14.11 Eurofarma

    14.12 Corporacion De Laboratorios Farmaceuticos

    14.13 Baxter International Inc.

    14.14 B. Braun

15 Conclusion
16 Methodology

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com